
According to IQVIA data MAT Nov 2022, India’s overall market of proteolytic enzyme for healing, pain and edema is around…
In the last financial year, India’s pharma exports stood at around USD 24.62 billion with the US, the UK, South…
Quarter performance beat estimates; FY23/24e EPS up 1/3%; target price revised to Rs 1,089; ‘Buy’ retained.
Reportedly, the Mumbai-based drug major is recalling the affected lot due to “water leakage” leading to deviation from current good…
The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…
BSE Sensex and Nifty 50 have rallied over 30 per cent so far in the year, and over 42 per…
On Wednesday, if the market falls below 20 days SMA, which is around 17500, we should be a contra buyer…
The intraday chart suggests, traders may take a caution stance near the 15900/53200 level
Cipla share price hit a new record high of Rs 997.20 apiece in intraday on BSE on Wednesday, after the…
Commenting on the company’s Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said…
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun…
Sanjiv Bhasin, Director at IIFL Securities Ltd, said that investors must stay invested as BSE Sensex and Nifty 50 have…
Pharmaceutical major Sun Pharma’s share price surged 4.2% on Friday morning despite the weaker sentiment in the domestic equity markets,…
Pharmaceutical sector will reflect the full impact of COVID-19 restrictions on the back of pre-buying in chronic therapies in March…
Sun Pharmaceuticals Industries stock has been on a gaining spree since it touched a 52-week low of Rs 315.20 in…
Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a…
The agreement involves transfer of these two marketing divisions along with employees to Strides for a consideration of Rs 165…
In September last year, Sun Pharma and Strides signed an agreement related to erstwhile Ranbaxy’s ‘Solus’ and ‘Solus Care’ divisions…
The FDA uploaded the Halol Warning Letter (WL) on its website, detailing various observations (i.e. cGMP deviations) cited during the…
Post issuance of the warning letter, approvals from Halol will continue to be withheld, which will impact future launches from…
Sun Pharma Laboratories Ltd, a wholly-owned subsidiary of the company, has raised, on private placement basis, Rs 1,000 crore by…
Divests Bryan unit to Nostrum Laboratories Sun Pharmaceutical Industries announced that as a part of its manufacturing consolidation in the…
Loading…
Something went wrong. Please refresh the page and/or try again.